Offer - Urjas Oil for just ₹ 1 X
Telmivas 3 Tablet is a prescription medicine that is available as a Tablet. It is primarily used for the treatment of High BP, Heart Failure, High BP. Other than this, Telmivas 3 Tablet has some other therapeutic uses, which have been discussed ahead.
The right dosage of Telmivas 3 Tablet depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
The side effects typically associated with Telmivas 3 Tablet include Back Pain. Besides the aforementioned side effects, there are other adverse effects of Telmivas 3 Tablet as well, which are listed below. Such side effects of Telmivas 3 Tablet normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Telmivas 3 Tablet is Safe for pregnant women and Safe for women who are breastfeeding. Warnings related to Telmivas 3 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Telmivas 3 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Telmivas 3 Tablet in conditions like Low Blood Pressure (Hypotension), Coronary Artery Disease (CAD), Liver Disease. Other contraindications of Telmivas 3 Tablet have been discussed in the sections ahead.
Drug reaction of Telmivas 3 Tablet with other medicines has been reported. Refer to the list below for further details.
In addition to the above precautions for Telmivas 3 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Telmivas 3 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Telmivas 3 Tablet safe for pregnant women?
Telmivas can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Telmivas 3 Tablet safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Telmivas. It should only be taken after medical advice.
What is the effect of Telmivas 3 Tablet on the Kidneys?
Telmivas rarely harms the kidneys.
What is the effect of Telmivas 3 Tablet on the Liver?
Telmivas is rarely harmful for the liver.
What is the effect of Telmivas 3 Tablet on the Heart?
Side effects of Telmivas rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Telmivas 3 Tablet unless your doctor advises you to do so -
Is this Telmivas 3 Tablet habit forming or addictive?
No, you will not get addicted to Telmivas 3 Tablet.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Telmivas 3 Tablet as you may feel sleepy.
Is it safe?
Yes, Telmivas 3 Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Telmivas 3 Tablet for mental disorders.
Interaction between Food and Telmivas 3 Tablet
Due to the absence of research, it is difficult to say how Telmivas 3 Tablet and food will interact.
Interaction between Alcohol and Telmivas 3 Tablet
Consumption of alcohol and Telmivas 3 Tablet together may have severe effects on your health.
Yes, Telmivas can be taken with ibuprofen. No harmful drug interaction has been reported between them. However, if you feel any discomfort after taking ibuprofen do not hesitate to inform your doctor.
Yes, [medicine] can cause stomach upset. It is a common side effect of this drug. Please inform your doctor if you are experiencing stomach upset after taking this medicine.
Telmivas comes in form of a tablet and ideally, it should be taken by mouth once daily as advised by your doctor. It can be taken with food or without food at any time of the day. Precautions must be taken in patients with liver disease, diabetes, and hypothyroidism.
Telmivas is calcium channel blocker. It works by inhibiting the movement of calcium into vascular smooth muscle cells and cardiac cells which inhibits the contraction of cardiac muscle and vascular smooth muscle and reduce electrical conduction within heart cell and dilate blood vessel. Dilation of the blood vessel reduces the blood pressure.
No, Telmivas should not be discontinued on your own. Discontinuation of a drug on your own can cause some serious problem such as blood pressure or chest pain which lead to heart attack and stroke. So before stopping this medicine, you must consult your doctor, he/she may switch your treatment if you can not tolerate this drug.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448